Page:Ultomiris (ravulizumab-cwvz) injection (Corrected Supplement Approval).pdf/7

From Wikisource
Jump to navigation Jump to search
This page has been proofread, but needs to be validated.

BLA 761108/S-021
Page 7

Tanya Wroblewski, MD
Associate Director of Therapeutic Review
Division of Nonmalignant Hematology
Office of Cardiology, Hematology,
Endocrinology, and Nephrology
Center for Drug Evaluation and Research

ENCLOSURES:
• Content of Labeling
o Prescribing Information
o Medication Guide
o Instructions for Use
• Carton and Container Labeling
• REMS

U.S. Food and Drug Administration
Silver Spring, MD 20993
www.fda.gov

Reference ID: 5019210